{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:36:05Z","timestamp":1791974165547,"version":"4.4.0"},"reference-count":110,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Theoretical considerations as well as comprehensive preclinical and clinical data suggest that optimizing physical parameters of intraperitoneal drug delivery might help to circumvent initial or acquired resistance of peritoneal metastasis (PM) to chemotherapy. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) is a novel minimally invasive drug delivery system systematically addressing the current limitations of intraperitoneal chemotherapy. The rationale behind PIPAC is: (1) optimizing homogeneity of drug distribution by applying an aerosol rather than a liquid solution; (2) applying increased intraperitoneal hydrostatic pressure to counteract elevated intratumoral interstitial fluid pressure; (3) limiting blood outflow during drug application; (4) steering environmental parameters (temperature, pH, electrostatic charge etc.) in the peritoneal cavity for best tissue target effect. In addition, PIPAC allows repeated application and objective assessment of tumor response by comparing biopsies between chemotherapy cycles. Although incompletely understood, the reasons that allow PIPAC to overcome established chemoresistance are probably linked to local dose intensification. All pharmacological data published so far show a superior therapeutic ratio (tissue concentration\/dose applied) of PIPAC vs. systemic administration, of PIPAC vs. intraperitoneal liquid chemotherapy, of PIPAC vs. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or PIPAC vs. laparoscopic HIPEC. In the initial introduction phase, PIPAC has been used in patients who were quite ill and had already failed multiple treatment regimes, but it may not be limited to that group of patients in the future. Rapid diffusion of PIPAC in clinical practice worldwide supports its potential to become a game changer in the treatment of chemoresistant isolated PM of various origins.<\/jats:p>","DOI":"10.3390\/cancers12010034","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T03:15:01Z","timestamp":1577070901000},"page":"34","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)"],"prefix":"10.3390","volume":"12","author":[{"given":"Giorgi","family":"Nadiradze","sequence":"first","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Horvath","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Sautkin","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0814-7723","authenticated-orcid":false,"given":"Rami","family":"Archid","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank-J\u00fcrgen","family":"Weinreich","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2301-4080","authenticated-orcid":false,"given":"Alfred","family":"K\u00f6nigsrainer","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Reymond","sequence":"additional","affiliation":[{"name":"National Center for Pleura and Peritoneum, University of T\u00fcbingen, 72076 T\u00fcbingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Cervantes","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.6004\/jnccn.2017.0036","article-title":"Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Benson","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdx738","article-title":"Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: A JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS","volume":"29","author":"Yoshino","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21277","article-title":"Looking up: Recent advances in understanding and treating peritoneal carcinomatosis","volume":"65","author":"Lambert","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: An analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: A longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.soc.2018.02.006","article-title":"Evolving Treatment Strategies and Outcomes in Advanced Gastric Cancer with Peritoneal Metastasis","volume":"27","author":"Dahdaleh","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/scientificamerican0794-58","article-title":"Barriers to drug delivery in solid tumors","volume":"271","author":"Jain","year":"1994","journal-title":"Sci. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrc1893","article-title":"Drug penetration in solid tumours","volume":"6","author":"Minchinton","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1515\/pp-2016-0015","article-title":"Functional vascular anatomy of the peritoneum in health and disease","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_12","first-page":"89","article-title":"Subcutaneous trastuzumab: Development of a new formulation for treatment of HER2-positive early breast cancer","volume":"6","author":"Hamizi","year":"2013","journal-title":"Onco. Targets Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/10717544.2019.1588423","article-title":"A 3D CFD model of the interstitial fluid pressure and drug distribution in heterogeneous tumor nodules during intraperitoneal chemotherapy","volume":"26","author":"Steuperaert","year":"2019","journal-title":"Drug Deliv."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure\u2014An obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jor.20633","article-title":"Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma","volume":"26","author":"Nathan","year":"2008","journal-title":"J. Orthop. Res."},{"key":"ref_16","first-page":"6400","article-title":"Interstitial Fluid Pressure Predicts Survival in Patients with Cervix Cancer Independent of Clinical Prognostic Factors and Tumor Oxygen Measurements","volume":"61","author":"Milosevic","year":"2001","journal-title":"Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1152\/physrev.1994.74.1.163","article-title":"Transport of macromolecules across microvascular walls: The two-pore theory","volume":"74","author":"Rippe","year":"1994","journal-title":"Physiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2015.01.004","article-title":"Epithelial-mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation","volume":"150","author":"Li","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"20180103","DOI":"10.1515\/pp-2018-0103","article-title":"Hypoxia, cytokines and stromal recruitment: Parallels between pathophysiology of encapsulating peritoneal sclerosis, endometriosis and peritoneal metastasis","volume":"3","author":"Wilson","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_20","first-page":"473134","article-title":"Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis","volume":"2014","year":"2014","journal-title":"Adv. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"Michelakis","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2174\/18715206113139990029","article-title":"Overcoming the blood-brain barrier for chemotherapy: Limitations, challenges and rising problems","volume":"14","author":"Wang","year":"2014","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1245\/s10434-017-5790-x","article-title":"Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols","volume":"24","author":"Loffler","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1055-3207(03)00051-6","article-title":"Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis","volume":"12","author":"Elias","year":"2003","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/pp-2016-0022","article-title":"Pharmacokinetic problems in peritoneal drug administration: An update after 20 years","volume":"1","author":"Flessner","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.V72225","article-title":"Small-solute transport across specific peritoneal tissue surfaces in the rat","volume":"7","author":"Flessner","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11095-019-2646-z","article-title":"High Pressure Nebulization (PIPAC) Versus Injection for the Intraperitoneal Administration of mRNA Complexes","volume":"36","author":"Shariati","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1245\/s10434-019-07695-z","article-title":"Comparison of Tissue and Blood Concentrations of Oxaliplatin Administrated by Different Modalities of Intraperitoneal Chemotherapy","volume":"26","author":"Bucur","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/00001813-199607000-00016","article-title":"Effects of intra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration","volume":"7","author":"Jacquet","year":"1996","journal-title":"Anticancer Drugs"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.sla.0000218089.61635.5f","article-title":"High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis","volume":"244","author":"Esquis","year":"2006","journal-title":"Ann. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0b013e3182582b38","article-title":"High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: An experimental study","volume":"256","author":"Facy","year":"2012","journal-title":"Ann. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.surg.2014.06.006","article-title":"High pressure does not counterbalance the advantages of open techniques over closed techniques during heated intraperitoneal chemotherapy with oxaliplatin","volume":"157","author":"Facy","year":"2015","journal-title":"Surgery"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","article-title":"Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites","volume":"32","author":"Garofalo","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.3802\/jgo.2019.30.e59","article-title":"Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study","volume":"30","author":"Petrillo","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kusamura, S., Azmi, N., Fumagalli, L., Baratti, D., Guaglio, M., Cavalleri, A., Garrone, G., Battaglia, L., Barretta, F., and Deraco, M. (2019). Phase II randomized study on tissue distribution and pharmacokinetics of cisplatin according to different levels of intra-abdominal pressure (IAP) during HIPEC (NCT02949791). Eur. J. Surg. Oncol.","DOI":"10.1016\/j.ejso.2018.07.029"},{"key":"ref_38","unstructured":"Hinds, W.C. (1999). Aerosol Technology, Wiley\u2014Interscience. [2nd ed.]."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/(SICI)1096-8628(20000214)90:4<328::AID-AJMG13>3.0.CO;2-F","article-title":"CHILD syndrome caused by deficiency of 3beta-hydroxysteroid-delta8, delta7-isomerase","volume":"90","author":"Grange","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/pp-2016-0023","article-title":"Morphology of the peritoneal cavity and pathophysiological consequences","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7453\/gahmj.2012.1.1.016","article-title":"Fever in Cancer Treatment: Coley\u2019s Therapy and Epidemiologic Observations","volume":"1","author":"Kienle","year":"2012","journal-title":"Glob. Adv. Health Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/02656736.2011.552087","article-title":"Autophagy, protein aggregation and hyperthermia: A mini-review","volume":"27","author":"Zhang","year":"2011","journal-title":"Int. J. Hyperth."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4613-1245-1_3","article-title":"Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis","volume":"81","author":"Stephens","year":"1996","journal-title":"Cancer Treat Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00104-019-0982-5","article-title":"Hyperthermic intraperitoneal chemotherapy","volume":"90","author":"Leebmann","year":"2019","journal-title":"Chirurg"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/pp-2016-0027","article-title":"Randomized controlled trials evaluating cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in prevention and therapy of peritoneal metastasis: A systematic review","volume":"1","author":"Eveno","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"20180131","DOI":"10.1515\/pp-2018-0131","article-title":"Cytoreductive Surgery (CRS) and Hyperthermic IntraPeritoneal Chemotherapy (HIPEC): Don\u2019t throw the baby out with the bathwater","volume":"3","author":"Konigsrainer","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"20180106","DOI":"10.1515\/pp-2018-0106","article-title":"Role of laparoscopy in initial tumour staging in advanced epithelial ovarian cancer: A systematic review","volume":"3","author":"Zeff","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"20180127","DOI":"10.1515\/pp-2018-0127","article-title":"The role of Pressurized IntraPeritoneal Aerosol Chemotherapy in the management of gastric cancer: A systematic review","volume":"4","author":"Garg","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"20190004","DOI":"10.1515\/pp-2019-0004","article-title":"Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: Safe access to the abdomen","volume":"4","author":"Glatz","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.ejso.2016.06.401","article-title":"Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis","volume":"42","author":"Ramos","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1007\/s00464-015-4708-6","article-title":"Eleven-year experience with 3000 cases of laparoscopic gastric cancer surgery in a single institution: Analysis of postoperative morbidities and long-term oncologic outcomes","volume":"30","author":"Park","year":"2016","journal-title":"Surg. Endosc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00423-017-1583-8","article-title":"Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis","volume":"402","author":"Pedziwiatr","year":"2017","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s004649900010","article-title":"Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator","volume":"14","author":"Reymond","year":"2000","journal-title":"Surg. Endosc."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: Proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/his.13829","article-title":"Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis","volume":"74","author":"Solass","year":"2019","journal-title":"Histopathology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1245\/s10434-012-2840-2","article-title":"Renal and hepatic toxicities after pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"20","author":"Blanco","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: First evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20180118","DOI":"10.1515\/pp-2018-0118","article-title":"Study protocol: Phase 1 dose escalating study of Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis","volume":"3","author":"Kim","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"20180120","DOI":"10.1515\/pp-2018-0120","article-title":"Phase I\/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design","volume":"3","author":"Dumont","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_61","first-page":"20180112","article-title":"Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane) for peritoneal carcinomatosis\u2014A phase I first-in-human study","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: A phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/pp-2016-0017","article-title":"Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2)","volume":"1","author":"Khomyakov","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20180107","DOI":"10.1515\/pp-2018-0107","article-title":"Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients\u2014Study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1758835919846402","DOI":"10.1177\/1758835919846402","article-title":"Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: A phase II study","volume":"11","author":"Struller","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"20180108","DOI":"10.1515\/pp-2018-0108","article-title":"Treatment of peritoneal carcinomatosis with Pressurized IntraPeritoneal Aerosol Chemotherapy\u2014PIPAC-OPC2","volume":"3","author":"Graversen","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e030408","DOI":"10.1136\/bmjopen-2019-030408","article-title":"Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: Protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)","volume":"9","author":"Rovers","year":"2019","journal-title":"BMJ Open"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20180114","DOI":"10.1515\/pp-2018-0114","article-title":"PIPAC-OV3: A multicenter, open-label, randomized, two-arm phase III trial of the effect on progression-free survival of cisplatin and doxorubicin as Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) vs. chemotherapy alone in patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer","volume":"3","author":"Bakrin","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_69","first-page":"20180113","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naive upper gi-adenocarcinomas with peritoneal seeding\u2014A phase II\/III trial of the AIO\/CAOGI\/ACO","volume":"3","author":"Pabst","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"20180116","DOI":"10.1515\/pp-2018-0116","article-title":"PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C\/D) in gastric peritoneal metastasis: A randomized and multicenter phase II study","volume":"3","author":"Eveno","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"20190010","DOI":"10.1515\/pp-2019-0010","article-title":"MESOTIP: Phase II multicenter randomized trial evaluating the association of PIPAC and systemic chemotherapy vs. systemic chemotherapy alone as 1st-line treatment of malignant peritoneal mesothelioma","volume":"4","author":"Sgarbura","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"20180119","DOI":"10.1515\/pp-2018-0119","article-title":"In search of evidence\u2014PIPAC on the fast lane","volume":"3","author":"Hubner","year":"2018","journal-title":"Pleura Peritoneum"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s00464-019-07043-y","article-title":"Assessment of the aerosol distribution pattern of a single-port device for intraperitoneal administration of therapeutic substances","volume":"33","author":"Seitenfus","year":"2019","journal-title":"Surg. Endosc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1245\/s10434-015-4954-9","article-title":"Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)","volume":"23","author":"Khosrawipour","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1245\/s10434-016-5108-4","article-title":"In Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC)","volume":"23","author":"Kakchekeeva","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: Proof of concept","volume":"26","author":"Solass","year":"2012","journal-title":"Surg. Endosc."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Shariati, M., Willaert, W., Ceelen, W., De Smedt, S.C., and Remaut, K. (2019). Aerosolization of Nanotherapeutics as a Newly Emerging Treatment Regimen for Peritoneal Carcinomatosis. Cancers, 11.","DOI":"10.3390\/cancers11070906"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1007\/s00464-015-4738-0","article-title":"Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model","volume":"30","author":"Son","year":"2016","journal-title":"Surg. Endosc."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"20190017","DOI":"10.1515\/pp-2019-0017","article-title":"A real-time ex vivo model (eIBUB) for optimizing intraperitoneal drug delivery as an alternative to living animal models","volume":"4","author":"Sautkin","year":"2019","journal-title":"Pleura Peritoneum"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tavernier, C., Passot, G., Vassal, O., Allaouchiche, B., Decullier, E., Bakrin, N., Alyami, M., Davigo, A., Bonnet, J.M., and Louzier, V. (2019). Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: An experimental study. Surg. Endosc., 1\u20138. in press.","DOI":"10.1007\/s00464-019-07076-3"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10637-018-0641-6","article-title":"Chemosensitivity of various peritoneal cancer cell lines to HIPEC and PIPAC: Comparison of an experimental duplex drug to standard drug regimens in vitro","volume":"37","author":"Weinreich","year":"2019","journal-title":"Invest. New Drugs"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"910","DOI":"10.7150\/jca.14714","article-title":"Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model","volume":"7","author":"Khosrawipour","year":"2016","journal-title":"J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.21873\/anticanres.11008","article-title":"Evaluating the Effect of Micropump(c) Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model","volume":"36","author":"Khosrawipour","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00432-016-2234-0","article-title":"Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model","volume":"142","author":"Khosrawipour","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/pp-2017-0015","article-title":"Experimental pharmacokinetics evaluation of chemotherapy delivery by PIPAC for colon cancer: First evidence for efficacy","volume":"2","author":"Eveno","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12957-017-1109-4","article-title":"Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cells","volume":"15","author":"Khosrawipour","year":"2017","journal-title":"World J. Surg. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12957-019-1633-5","article-title":"Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC)","volume":"17","author":"Schubert","year":"2019","journal-title":"World J. Surg. Oncol."},{"key":"ref_89","first-page":"483","article-title":"Release of doxorubicin from its liposomal coating via high intensity ultrasound","volume":"11","author":"Mikolajczyk","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fphar.2019.00669","article-title":"Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx((R))) as Pressurized Intraperitoneal Aerosol Chemotherapy","volume":"10","author":"Robella","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_91","unstructured":"(2019, December 19). Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Doxorubicin."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ejso.2011.04.007","article-title":"Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis","volume":"37","author":"Sugarbaker","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: An international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_94","first-page":"501","article-title":"Modification of the hemodynamic parameters and peripheral vascular flow in a porcine experimental of model of laparoscopic nephrectomy","volume":"60","year":"2007","journal-title":"Arch. Esp. Urol."},{"key":"ref_95","first-page":"378","article-title":"Splanchnic microcirculatory changes during CO2 laparoscopy","volume":"184","author":"Schilling","year":"1997","journal-title":"J. Am. Coll. Surg."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: Rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1470-2045(03)01074-X","article-title":"Intraperitoneal antineoplastic drug delivery: Rationale and results","volume":"4","author":"Markman","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-018-9895-9","article-title":"Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): Report of two cases and literature survey","volume":"35","author":"Graversen","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-018-4784-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: Systematic review of clinical and experimental evidence with special emphasis on ovarian cancer","volume":"298","author":"Tempfer","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00464-016-5174-5","article-title":"Technical description of the microinjection pump (MIP((R))) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC)","volume":"31","author":"Gohler","year":"2017","journal-title":"Surg. Endosc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00464-017-5652-4","article-title":"Scintigraphic peritoneography reveals a non-uniform (99m)Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model","volume":"32","author":"Bellendorf","year":"2018","journal-title":"Surg. Endosc."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.21873\/anticanres.12613","article-title":"Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) via Endoscopical Microcatheter System","volume":"38","author":"Khosrawipour","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_103","unstructured":"Levin, E.A., and Ceelen, W.P. (2016). Intraperitoneal Cancer Therapy: Principles and Practice, CRC Press (Taylor and Francis)."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00464-014-3427-8","article-title":"Electrostatic precipitation is a novel way of maintaining visual field clarity during laparoscopic surgery: A prospective double-blind randomized controlled pilot study","volume":"28","author":"Ansell","year":"2014","journal-title":"Surg. Endosc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1515\/pp-2016-0005","article-title":"Electrostatic precipitation Pressurized IntraPeritoneal Aerosol Chemotherapy (ePIPAC): First in-human application","volume":"1","author":"Reymond","year":"2016","journal-title":"Pleura Peritoneum"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.ejso.2019.06.018","article-title":"Safety and preliminary efficacy of electrostatic precipitation during pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable carcinomatosis","volume":"45","author":"Willaert","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Graversen, M., Detlefsen, S., Ellebaek, S.B., Fristrup, C., Pfeiffer, P., and Mortensen, M.B. (2019). Pressurized IntraPeritoneal Aerosol Chemotherapy with one minute of electrostatic precipitation (ePIPAC) is feasible, but the histological tumor response in peritoneal metastasis is insufficient. Eur. J. Surg. Oncol.","DOI":"10.1016\/j.ejso.2019.08.024"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/pp-2017-0004","article-title":"Modelling drug transport during intraperitoneal chemotherapy","volume":"2","author":"Steuperaert","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41551-018-0306-y","article-title":"Computational fluid dynamics with imaging of cleared tissue and of in vivo perfusion predicts drug uptake and treatment responses in tumours","volume":"2","author":"Sweeney","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"ref_110","unstructured":"Rahimi-Gorji, M.B.S., Debbaut, C., Descamps, D., Pullens, P., Segers, P., Sourbron, W., and Ceelen, W. (2019, January 27). Validation of a computational fluid dynamics model of drug delivery and interstitia\u00f6 fluid pressure in ovarian cancer xenografts. Proceedings of the 5th ISSPP Workshop on Basic Science, Paris, France."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/34\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:44:20Z","timestamp":1760190260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/34"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["cancers12010034"],"URL":"https:\/\/doi.org\/10.3390\/cancers12010034","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,20]]}}}